Clinical

Dataset Information

A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors


ABSTRACT: This proposed Phase I clinical trial of SON-DP is an FIH, open-label, Phase Ia/Ib dose escalation and expansion study to evaluate the safety, tolerability, PK, and PD of SON-DP in participants with relapsed/refractory/intolerant to standard of care therapies, for advanced/ metastatic solid tumors.

DISEASE(S): Ovarian Cancer,Solid Tumor,Colorectal Cancer,Colorectal Neoplasms,Pancreatic Cancer,Ovarian Neoplasms,Pancreatic Neoplasms,Breast Cancer

PROVIDER: 69608 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR